Biotechnology News

December 3, 2012

TUCSON, Ariz.--(BUSINESS WIRE)--Bruker announced today that it has already received more than $7 million in orders for its new Bruker SP9900+ high-throughput high density interconnect (HDI) substrate metrology system, and has begun shipping the...

December 3, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced it has started a Phase II/III clinical trial designed to evaluate the safety and efficacy of MK-8931 versus placebo in...

December 3, 2012

CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) and Astellas Pharma Inc. (TSE: 4503) today announced the initiation of patient enrollment in a randomized, double-blind, multicenter Phase 2 clinical trial, called BATON-...

December 3, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ: IMGN), a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that there will be...

December 3, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Issues Shareholder Letter Celebrating Promising 2013

December 3, 2012

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--Gore Receives CE Mark for New Large Diameter GORE® EXCLUDER® AAA Endoprosthesis. New size allows more patients with large aortic neck diameters to benefit from endovascular treatment

November 30, 2012

BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Announces Approval of a Supplemental Application for Updates to AMITIZA (lubiprostone) Pregnancy Labeling

November 30, 2012

PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, announced today that Edward J. Quilty, the Company’s chief executive officer, will present a...

November 30, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: As per November 30, 2012, the total number of shares in Vitrolife AB (publ) (STO:VITR) amounts to 19,830,936, of which Vitrolife itself holds 0 shares. The share capital amounts to SEK 20,227,...

November 30, 2012

SAN DIEGO--(BUSINESS WIRE)--For the second year, Lundbeck and the Epilepsy Foundation (EF) will exhibit artwork from Studio E: The Epilepsy Art Therapy Program at the American Epilepsy Society (AES) Annual Meeting. Studio E offers weekly group...

November 30, 2012

VIENNA, Va.--(BUSINESS WIRE)--The following letter is being released by CEL-SCI Corporation (NYSE MKT: CVM) to its shareholders: Dear Fellow Shareholders: As you know, we are currently running the largest ever Phase III clinical trial in head and...

November 30, 2012

PHILADELPHIA--(BUSINESS WIRE)--iCeutica’s reformulation of metaxalone is designed to create an improved lower dose product with distinct advantages over other muscle relaxants. This trial is the 14th to be conducted on SoluMatrix.

November 30, 2012

HATFIELD, Pa. & WYNNEWOOD, Pa.--(BUSINESS WIRE)--Genisphere and the nonprofit Lankenau Institute for Medical Research (LIMR), which are already making progress together on identifying Inflammatory Bowel Disease biomarkers, have partnered to...

November 30, 2012

NEEDHAM, Mass.--(BUSINESS WIRE)--Celldex Therapeutics to present at the Deutsche Bank 2012 dbAccess BioFEST on Monday, December 3, 2012 at 2:50 pm ET at the Four Seasons Hotel in Boston, MA; presentation will be webcast.

November 30, 2012

WEST PALM BEACH, Fla. & BOSTON--(BUSINESS WIRE)--Xcovery’s X-82, a dual VEGFR/PDGFR inhibitor, was named a Hot Project to Watch in the Hot Space category for ophthalmology as the first patient was dosed in its Phase I/II clinical study for...

November 30, 2012

PARIS--(BUSINESS WIRE)--THERAVECTYS, a French biotechnology company currently developing a new generation of vaccines, today announced it was granted authorization by the National Security Agency for Medicines and Health Products in France (...

November 30, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to present at Deutsche Bank’s 2012 dbAccess BioFEST on Tuesday, December 4, 2012, at 9:00 AM ET.

November 30, 2012

RESEARCH TRIANGLE PARK, N.C. & SAN FRANCISCO--(BUSINESS WIRE)--BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) and privately held Presidio Pharmaceuticals, Inc. today announced the mutual termination of the Merger Agreement and the related...

November 30, 2012

--(BUSINESS WIRE)--VTU Technology GmbH - Pichia pastoris protein expression services and bioprocess development

November 29, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida reports patient access scheme being developed by Alimera to address cost concerns following negative final draft guidance by UK's NICE for ILUVIEN for DME

November 29, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it will host a conference call and live webcast on Friday, November 30, 2012 at 8:00 a.m. ET to communicate its 2013 business outlook. A Question...

November 29, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories schedules its 2013 financial guidance press release and conference call for Wednesday, December 12, 2012

November 29, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ) announced today that its Board of Directors has authorized a share repurchase of up to $1 billion of its outstanding common stock. The repurchases will occur at such times and at...

November 29, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) today announced the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application (MAA) for COMETRIQ™ (cabozantinib) for the proposed...

November 29, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ: EXEL) today announced that the U.S. Food and Drug Administration (FDA) has approved COMETRIQ™ (cabozantinib) for the treatment of progressive, metastatic medullary thyroid...

November 29, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem will present data on two of its programs that target cancer stem cells at the San Antonio Breast Cancer Symposium on December 8, 2012.

November 29, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), a vertically integrated biosciences and clinical laboratory company, announced today that Barry Weiner, President, and David Goldberg, Vice President, Corporate Development, will be...

November 29, 2012

WASHINGTON--(BUSINESS WIRE)--Sens. Hagan (NC) and Johnson (SD) have sponsored amended language to the Natl Defense Authorization Act of 2013 that will block the DoD's participation in public-private biofuels production.

November 29, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) today dedicated a new facility in Research Triangle Park (RTP), consolidating its 300-person Patient Services operation with the existing RTP campus. The new 190,000 square...

November 29, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological...

November 29, 2012

HOUSTON--(BUSINESS WIRE)--Pulmotect wins 2012 SEBIO Early Stage Shootout. Novel technology to broadly boost the host immune system against inhaled pathogens.

November 29, 2012

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences announced that the company will present at the Canaccord Genuity Medical Technology & Diagnostics Forum on Dec. 4 at 10 a.m. ET.

November 29, 2012

NORWALK, Conn. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF), a non-profit organization dedicated to accelerating research and the development of improved therapeutics leading to a cure for multiple...

November 29, 2012

FORT WASHINGTON, Pa.--(BUSINESS WIRE)--New Value Pathways collaboration from NCCN, US Oncology Network and McKesson Specialty Health to provide new, evidence-based clinical quality standards in the oncology market and address cost trends.

November 29, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets has announced the addition of the "Molecular Aspects of Neurodegeneration and Neuroprotection" book to their offering. Neurodegenerative diseases are a complex heterogeneous group of diseases...

November 29, 2012

WILMINGTON, N.C.--(BUSINESS WIRE)--PPD today announced it has been recognized by Scrip Intelligence with its 2012 award for Best Technological Development in Clinical Trials for cutting-edge solutions advancing clinical research.

November 29, 2012

NEW YORK--(BUSINESS WIRE)--OneMedPlace announces program updates for its 6th annual “OneMedForum,” Jan. 7-9, 2013, in San Francisco

November 29, 2012

IRVINE, Calif.--(BUSINESS WIRE)--CardiAQ™ Valve Technologies, Inc. Completes $37.3 Million Series B Round of Financing Led by OrbiMed Advisors LLC

November 29, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--REXAHN PHARMACEUTICALS, INC. (NYSE MKT: RNN) today announced the pricing of an underwritten public offering of 19,130,435 shares of its common stock and warrants exercisable for up to 10,521,739 additional shares...

November 29, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, Ph.D. will present at...

November 29, 2012

BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation hired Richard Reiter as Director of Technical Support. PHT is the leading provider of innovative technology systems used to collect patient-driven eData for clinical research.

November 29, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of psoriasis, surveyed dermatologists estimate that half of...

November 29, 2012

FORT COLLINS, Colo.--(BUSINESS WIRE)--VetDC, Inc., announced today the completion of a $1.5 million private financing. The funds will be used to advance VDC-1101 towards veterinary approval in canine lymphoma.

November 29, 2012

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTC:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today that its senior management will hold a conference call on...

November 29, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision completes enrollment of its Phase 3 clinical trial of BromSite. BromSite is being developed to address inflammation and pain following cataract surgery.

November 29, 2012

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a biopharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today that its Phase 3 study of Gattex (...

November 29, 2012

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (NASDAQ: TRNS) (“Transcat” or the “Company”), a leading distributor of professional grade handheld test, measurement and control instruments and accredited provider of calibration, repair,...

November 29, 2012

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck, known as MSD outside the U.S. and Canada, announced today that it has formally notified the European Medicines Agency (EMA) of Merck's decision to withdraw the Marketing Authorisation Application...

November 29, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets has announced the addition of the "Frontiers In Pluripotent Stem Cells Research And Therapeutic Potentials" book to their offering. Pluripotent stem cells have garnered tremendous interest in...